• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/29

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

29 Cards in this Set

  • Front
  • Back

AMPK

Activated by elevated AMP or decreased ATP by exercise, by sympathetic system or by peptide hormones

Some enzymes in the pathway limit metabolites more than others

Not all regulated enzymes have same effect on the entire pathway


Some control flux through pathway while others regulate steady state concentrations in response to changes in flux


Ie: hexokinase and phosphofructokinase regulate glycolytic flux: increase hexo to activate glucose and increase PFK-1 catalizes glucose via glycolysis. Hexo has more influence though

There are 4 isozymes of hexokinase (different variant of the same enzyme)

HK 1: expressed in all tissues


HK IV (glucokinase): only expressed in the liver, higher Km so more sensitive to high levels of glucose which enables it to clear it from blood for storage when higher levels


Also Not inhibited by glucose-6-PO3


HK IV is regulated by sequestration and transcription

When glucose levels are low in the blood, to shut down HK IV binds to regulatory protein and goes into nucleus


To get HK back to cytosol, glucose stimulates receptors GLUT2


HK returns glucose -6-phosphate and fructose-6-phosphate and continues feedback loop

Regulation of phosphofructokinase-1 (the conversion of frustose-6-phosphate to fructose 1,6-biphosphate

Commitment step where adding a phosphate we have committed molecule to glycolysis


High levels of AMP lead to this while high levels of ATP inhibit it


Citrate also inhibits it due to fatty acid cycle being activated which further confirms the cell has lots of E and we don’t need to make more through glycolysis

Regulation of phosphofructokinase-1 and fructose 1,6-bisphosphatase

For glycolysis: AMP/ADP is high, ATP is low. Activates PFK-1. AMP also inhibits FBpase-1 to prevent gluconeogenesis


For gluconeogenesis: AMP is low, ATP is high

Fructose 2,6-bisphosphate

Not a glycolytic intermediate, only a regulator


Produced specifically to regulate glycolysis and gluconeogenesis by activating PFK-1 and inhibiting FBPase-2

Glycolysis and gluconeogenesis are regulated by F-2,6-bP

F26BP activates PFK-1 and inhibits FBPase-1

Regulation of F-2,6-bP levels

A Multifunction singular protein with PRK-2/FBPase-2 combined


One side adds PO3 and the other pulls it off


When FBPase side is active, stimulates glycolysis and inhibits gluconeogenesis


when PKF-2 is active, stimulates gluconeogenesis and inhibits glycolysis

Pyruvate kinase regulation

Allosterically activated by fructose-1,6-bispophosphate


Allostericallyinhibit by signs of increased E supply (atp, acetyl-CoA, alanine)


Inhibited by phosphorylation when glucose depletion occurs (in liver)

The flexibility of pyruvate

Eat a carb rich meal:


Pyruvate is first forming ATP through glycolysis


When ATP is high, gluconeogenesis is activated.


When glycogen storage is full, can convert to acetyl CoA and store fatty acids

Glucose can be stored later for use as glycogen

Glycogen is a branched polymer of alpha 1-4 with alpha 1-6linkages every 12-14 glucose units


Occurs mainly in liver and muscle


Degraded to glucose for E


Can be made from excess blood glucose or recycling glycogenic metabolites like lactate or certain AAs

Breakdown of glycogen

Starts at reducing end


Take off a unit of glucose but add a PO3 group to it (glycogen phosphorylase)


Product made is a glucose-1-phosphate

How it does this with branching

Glycogen phosphorylase Cuts off at all nonreducing ends until it reaches 4 residues from a branch point but can’t go any further


Debranching enzyme can then move 3 of the 4 molecules to the end of another branch


Then goes in and cleaves off last glucose molecule which becomes a free molecule

Glucose-1-phosphate (single glucose molecule) must be isomerized to glucose-6-phosphate for metabolism

Phosophoglucomutase performs this rxn

To transfer glucose-6-phosphate out of the liver…

Glucose-6-phosphatase is sequestered in the ER lumen


Dephosphorylates glucose-6-phosphate in the liver


Uses concentration gradient to control flux out of liver

Glycogen synthesis from glucose in multiple steps

Needs more enzymes


Must be phosphorylated, labeled with UDP, and added to glycogen


Multiple steps allow for multiple regulation points

Gloves synthesis

Use enzyme glycogen synthase


Glucose molecule is attached to UDP glucose (uracil w PO3)


Then adds to nonreducing end

UDP glucose (uradene) and how it is formed

See pic

Synthesis of branches in glycogen

After 6 or 7 glucose molecules, glycogen-branching enzyme cleaves and reattached 4 glucose molecules towards core


Product is one 4 molecule chain and one 1-6 molecule chain with nonreducing ends

Glycogenin molecule (core)

Creates new glucose chains using UDP starting with a primer of 6 glucose molecules


Then more chains build out from there

Layout of glycogen synthesis and degradation

See pic

Control of glycogen breakdown

Flu gig in/epinephrine signaling pathway starts phosphorylation cascade via cAMP and activates glycogen phosphorylase


Glycogen phosphorylase cleaves glucose residues off creating glucose-1-phosphate

Epinephrine & glucagon stimulate breakdown of glycogen

See pic

Control of glycogen synthesis

Insulin-signaling pathway increases glucose into muscle, stims hexokinase, and activates glycogen synthase


Makes glycogen for E storage

Glycogen synthase is controlled by phosphorylation

When phosphorylated, Inhibited


So when we want glycogen, add PO3 groups

Glycogen-targeting protein (GM)

Can be phosphorylated by insulin or epinephrine (opposite rxn)


Family of proteins

Summary graph in book

Page 70

In liver pathways

Page 570